Aspartame: The Surprisingly Interesting Science and History (Episode 116)

Saccharin, discovered in 1879, was derived from coal tar, which sounded alarming. It was introduced in an era of unregulated 'patent medicines,' and later even saw the head of the FDA fired for trying to investigate it, further fueling distrust among the public when it was labeled an 'adulterant' in 1911.

Aspartame's approval was fraught with issues, including GD Searle's submitted studies being deemed 'poorly conceived' by an FDA task force. A U.S. attorney investigating Searle was hired by the company's law firm, delaying the inquiry. Later, a new FDA head, appointed by President Reagan (a friend of Searle's chairman Donald Rumsfeld), quickly approved aspartame and then took a job as a consultant for Searle's public relations agency. This revolving door between government and industry significantly increased public skepticism.

In 1999, a widely circulated chain email, falsely attributed to an expert named Nancy Markle, claimed aspartame caused a vast array of severe conditions including multiple sclerosis, lupus, blindness, seizures, depression, and death. This hoax effectively spread misinformation on the early internet and even prompted an official debunking from the FDA.

In the 1980s, New York Times coverage largely reassured the public of aspartame's safety despite underlying controversies. The 1990s were quiet, focusing mainly on new sweetener formulations. However, in the 2000s, media sentiment shifted, with articles expressing skepticism, often citing the controversial Ramazzini studies and questioning industry-funded research, largely fueled by internet misinformation.

The Ramazzini Institute published rodent studies in the mid-2000s, claiming aspartame caused a wide range of cancers. The studies were heavily criticized by regulatory bodies and independent scientists for methodological flaws, including inadequate experimental design, misidentified tumors, improper randomization, and signs of unhealthy animals, making their findings unreliable.

IARC assesses whether something 'can' cause cancer (a hazard), focusing on the strength of scientific evidence, not the likelihood (risk) it will cause cancer at typical exposure levels. Risk assessment, conducted by agencies like JECFA, considers exposure levels and calculates the actual probability of harm, guiding safe consumption guidelines.

Group 2B is a 'dumping ground' for substances with any inkling of evidence of carcinogenicity, not necessarily a high risk. It includes common items like ginkgo biloba, aloe vera extract, and even 'putting talcum-based baby powder on your perineum.' The classification indicates limited evidence from human, animal, and mechanistic studies, and does not provide an estimate of actual risk from normal consumption.

Aspartame breaks down into phenylalanine, aspartate (both common amino acids found in protein), and methanol. The amounts of these components, even at maximum allowable aspartame intake, are less than or comparable to what the body naturally encounters from a normal diet (e.g., more methanol from fruit juices), making the trace amounts generated from aspartame biologically implausible to be harmful.

JECFA (Joint Expert Committee on Food Additives), another WHO body responsible for risk assessment, reviewed the same evidence as IARC and found no new data indicating a greater risk than previously assumed. Therefore, they reaffirmed the acceptable daily intake of 40 mg/kg, emphasizing that IARC's hazard classification doesn't directly translate to individual consumption risk.

It's important to focus on 'big rocks' for health, like not smoking, moderate drinking, healthy weight, exercise, sleep, and eating fruits and vegetables. Beyond that, evaluate risks by understanding the 'why' (mechanism), 'to what extent' (magnitude of risk), and 'dose-response' relationship, rather than succumbing to fear from isolated headlines, and remember to balance risk avoidance with a fulfilling life.

Residual confounding occurs in observational studies when a variable of interest (e.g., diet soda) is associated with an outcome (e.g., cancer) due to its correlation with other unmeasured or inaccurately measured factors (confounders). This can create spurious associations, making it appear that the variable directly causes the outcome when it doesn't, highlighting the importance of mechanistic evidence alongside associations.

While skepticism is healthy, not all industry-funded research is nefarious. Companies have strong incentives to ensure their products are genuinely safe to avoid lawsuits and bans, especially with easily substitutable ingredients like artificial sweeteners. They also often possess the most extensive safety data due to ongoing monitoring requirements. Therefore, industry-funded findings should be critically evaluated but not automatically dismissed.

The naturalistic fallacy leads people to assume that anything 'natural' is inherently good or safe, while 'artificial' things are bad or dangerous. This bias often makes people more accepting of sugar (a 'natural' product) despite its well-established harms, while being overly skeptical of artificial sweeteners because they are industrially produced. It's a useful heuristic but not an absolute rule, as many natural substances are harmful and many artificial ones are safe.